Did You Know?

Did you know that the FDA is developing a standardized format for REMS?


Jan 04, 2010 | Free Downloads | email | Print

Share This Article





Drug companies know how difficult it can be to develop a solid risk evaluation and mitigation strategy (REMS). In fact, the process can be so difficult that even those assigned to develop the strategy spend much of their time confused about what it is that the FDA wants/requires in a REMS.

The FDA therefore is developing a new standardized format for REMS. The structure of the new framework should be easier to understand and should allow professionals access to a more consistent set of "instructions."



Share This Article





Watch Related Videos


Download Free Resources
Q&A: Risk Management for Pharmaceutical Companies Under FDA's Q9 Guidance
Webinar: GAMP 5 - A Risk-based Approach to Compliant GxP Computerized Systems
White Paper: GAMP®5: A Risk-based Approach to Compliant GxP Computerized Systems
Product Data Sheet: MasterControl Risk Analysis™
Product Data Sheet: MasterControl Risk™